Multiple eruptive squamous cell carcinoma in a patient with chronic plaque psoriasis on adalimumab
1Department of Dermatology, Waikato Hospital, Hamilton, New Zealand. susansimpkin@gmail.com
Abstract:
A 67-year-old man with chronic plaque psoriasis previously treated with psoralen plus PUVA, ciclosporin, methotrexate and acitretin developed eruptive squamous cell carcinoma after seven doses of adalimumab. We review the association of squamous cell carcinoma with immunosuppressive agents used for the treatment of chronic plaque psoriasis. Initiation of tumour necrosis factor (TNF)-α inhibitors in a patient at high risk of non-melanoma skin cancer may warrant chemoprophylaxis with acitretin.
Related Concept Videos
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Staphylococcal Skin Infections
Clinical Applications of Epidermal Stem Cells
